Characterization of anti-psychotic agents as lung cancer stem cell inhibitors
碩士 === 國立陽明大學 === 生物藥學研究所 === 105 === Lung cancer is the leading cause of cancer death around the world. There are two major types of lung cancer: small cell lung cancer and non-small cell lung cancer (NSCLC). Cisplatin plus gemcitabine are used to treat to squamous lung cancer; cisplatin plus pemet...
Main Authors: | Po-Wei Huang, 黃柏維 |
---|---|
Other Authors: | Jin-Hwang Liu |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/50668097168788386368 |
Similar Items
-
QSAR analysis and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2019-10-01) -
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
by: Xiubao Ren, et al.
Published: (2017-04-01) -
Synthesis and characterization of impurities of an anti-psychotic drug substance, Olanzapine
by: Poornachander Thatipalli, et al.
Published: (2008-04-01) -
Criminal Liability of Behaviors of Individuals with Psychotic Disorders or Dissociative Identity Disorder
by: Po-Hsiang Huang, et al.
Published: (2008) -
Effect of the Hedgehog Pathway inhibitor GDC-0449 in lung cancer cells and lung cancer stem cells
by: Tian, Fei
Published: (2013)